Literature DB >> 8519663

Cytotoxic effect of RB 6145 in human tumour cell lines: dependence on hypoxia, extra- and intracellular pH and drug uptake.

L D Skarsgard1, D K Acheson, A Vinczan, B G Wouters, B E Heinrichs, D A Loblaw, A I Minchinton, D J Chaplin.   

Abstract

Low pH and hypoxia are a common feature of many solid tumours. This study examined the effect of these two conditions on the cytotoxic properties of the bifunctional agent RB 6145, the prodrug of RSU 1069. The effect of acidic pH on RB 6145 toxicity was examined in six human tumour cell lines under hypoxic conditions and was found to have little effect in HT 29, A549, U373 and HT 144 cells. Treatment was for 1 h at 37 degrees C, pH 6.4 or 7.4. Significant potentiation of RB 6145 toxicity was observed in SiHa cells (enhancement ratio; ERpH approximately 1.6) and in U1 cells (ERpH approximately 1.4). In these two cell lines the potentiation of RB 6145 toxicity arising from hypoxia was large, with ERHyp approximately 11 and 15 in SiHa and U1 cells respectively. SiHa cells, which show a pH effect and HT 29 cells, which do not, were chosen for further comparative studies of drug uptake )nd regulation of intracellular pH. High-performance liquid chromatography (HPLC) determinations of the uptake of RB 6145 and its dervatives showed that in SiHa cells, intracellular to extracellular drug concentration ratio (Ci/Ce) at 1 h was approximately 40% higher at pH 6.4 than at pH 7.4, whereas in HT 29 cells Ci/Ce was approximately 25% lower. Under conditions of acidic extracellular pH, regulation of pH was somewhat less effective in SiHa cells, where pHi dropped to within 0.2 pH units of the extracellular pH over a 2.5 h treatment at pH 6.4. It seems likely that increased drug uptake was at least part of the basis for the observed potentiation of RB 6145 toxicity in SiHa cells. A model which would better explain the results for both cell lines might also include the possibility that low pH per se potentiates cytotoxic damage to a modest extent and that it is offset or augmented by altered uptake in HT 29 and SiHa cells respectively.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8519663      PMCID: PMC2034082          DOI: 10.1038/bjc.1995.533

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

Review 1.  Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapy.

Authors:  S Dische
Journal:  Radiother Oncol       Date:  1985-02       Impact factor: 6.280

2.  A toxicity and pharmacokinetic study in man of the hypoxic-cell radiosensitiser RSU-1069.

Authors:  A Horwich; S B Holliday; J M Deacon; M J Peckham
Journal:  Br J Radiol       Date:  1986-12       Impact factor: 3.039

Review 3.  The relevance of tumour pH to the treatment of malignant disease.

Authors:  J L Wike-Hooley; J Haveman; H S Reinhold
Journal:  Radiother Oncol       Date:  1984-12       Impact factor: 6.280

Review 4.  Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneity.

Authors:  C N Coleman
Journal:  J Natl Cancer Inst       Date:  1988-05-04       Impact factor: 13.506

5.  Cellular uptake of misonidazole and analogues with acidic or basic functions.

Authors:  M F Dennis; M R Stratford; P Wardman; M E Watts
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1985-06

6.  Studies on the toxicity of RSU-1069.

Authors:  G F Whitmore; S Gulyas
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-07       Impact factor: 7.038

7.  The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour.

Authors:  I F Tannock
Journal:  Br J Cancer       Date:  1968-06       Impact factor: 7.640

8.  Dual-function radiation sensitizers and bioreductive drugs: factors affecting cellular uptake and sensitizing efficiency in analogues of RSU 1069.

Authors:  J Walling; I J Stratford; G E Adams; M A Stephens
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1988-04

9.  RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivo.

Authors:  G E Adams; I Ahmed; P W Sheldon; I J Stratford
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-09       Impact factor: 7.038

10.  The histological structure of some human lung cancers and the possible implications for radiotherapy.

Authors:  R H THOMLINSON; L H GRAY
Journal:  Br J Cancer       Date:  1955-12       Impact factor: 7.640

View more
  2 in total

1.  Enhanced intercellular retention activity of novel pH-sensitive polymeric micelles in wild and multidrug resistant MCF-7 cells.

Authors:  Ghazal Mohajer; Eun Seong Lee; You Han Bae
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.200

2.  In vivo tumour extracellular pH monitoring using electron paramagnetic resonance: the effect of X-ray irradiation.

Authors:  Jonathan Goodwin; Katsuya Yachi; Masaki Nagane; Hironobu Yasui; Yusuke Miyake; Osamu Inanami; Andrey A Bobko; Valery V Khramtsov; Hiroshi Hirata
Journal:  NMR Biomed       Date:  2014-01-28       Impact factor: 4.044

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.